Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (The Z-AMD Study): A Randomized Controlled Pilot Study

NCT04304755 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04304755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04304755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (The Z-AMD Study): A Randomized Controlled Pilot Study
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Completed
Start date
October 25, 2021
Completion date
January 24, 2024
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration